After transportation into the tumor interstitium via the caveolae-mediated pathway, nab-PTX could bind to SPARC, facilitating the release of PTX around cancer tissues and improving the anticancer effects (Abu Samaan et al., 2019). Here, SPARC is linked to cancer.